CGEM FY 2019 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$841M

FY 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$70,000

Operating Income

-$22M

Net Income

-$20M

EPS (Diluted)

$-19.68

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$100M

Total Liabilities

$140M

Stockholders' Equity

-$41M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$70,000	-$43,000	-62.8%
Operating Income	-$22M	-$15M	-52.7%
Net Income	-$20M	-$14M	-41.2%